arrow
F

Francesco De Cobelli

IRCCS San Raffaele Scientific Institute
H指数:64
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study

PD-L1 ≥ 50% 非小细胞肺癌中cemiplimab单药或联合短程化疗的超进展:一项生物标志物指导的多中心国际II期试验—HYPERBOLIC研究

2026-09-010
PRE
Prognostic models and predictors of recurrence in resectable colorectal liver metastases: A systematic review and meta-analysis

可切除结直肠癌肝转移的预后模型和复发预测因素:一项系统评价和荟萃分析

2026-09-010
PRE
MULTIDISCIPLINARY MANAGEMENT OF VON HIPPEL-LINDAU DISEASE THROUGHOUT THE PATIENT'S LIFETIME: OBSERVATIONAL ANALYSIS FROM A LARGE COMPREHENSIVE CARE CENTER

von Hippel-Lindau疾病的多学科终身管理:来自大型综合护理中心的观察分析

2026-05-010
PRE
Personalized dosimetry enhances hepatocellular carcinoma response in Yttrium-90 resin microsphere radioembolization

个性化剂量测定增强了钇-90树脂微球放射栓塞疗法对肝细胞癌的响应

2026-04-280
OAAI
Inter- and intra-rater variability of MRI-based lesion size measurements in active surveillance for prostate cancer: a multicentre study

基于MRI的病变大小测量在前列腺癌主动监测中的评分者间和评分者内变异性:一项多中心研究

2026-02-060
OAAI
Diagnostic Accuracy of Fully Hybrid PET/MRI with Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard

Ghezzo, S.; Mapelli, P.; Cogrossi, L.L.; Gajate, A.M.S.; Brembilla, G.; Cucchiara, V.; Mattorre, B.; Russo, T.; Bezzi, C.; Neri, I.; 等. 完全混合PET/MRI在检测原发性前列腺癌中的诊断准确性:以组织学为金标准的2期试验([68Ga]Ga-PSMA-11和[68Ga]Ga-RM2)。J. Nucl. Med. 2026, 67, 232–238. [Google Scholar] [CrossRef] [PubMed]

2026-02-011
PRE
Multimodal Prehabilitation In Pancreatic cancer Patients undergoing surgery (PIPS): study protocol for a randomized controlled trial

Pecorelli, N.; Fermi, F.; Abati, M.; Bonomi, B.; Fossati, L.; Corti, G.; Guarneri, G.; Macchini, M.; Damascelli, A.; Palumbo, D.; 等. 多模式术前康复在行手术治疗的胰腺癌患者中的应用(PIPS):一项随机对照试验的研究方案. Trials 2026, 27, 184. [Google Scholar] [CrossRef]

2026-01-311
PRE
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment

[18F]FDG PET/MRI在内膜癌中的应用:术前分期、分子特征和预后评估的前瞻性评价

Cancers
IF4.4
2026-01-170
OAAI
Does the Accuracy of Prostate-specific Antigen Density in Identifying Clinically Significant Prostate Cancer Change with Prostate Volume?
2025-12-230
PRE
INCORPORATING INDIVIDUAL EARLY RESPONSE IN THE DOSE-EFFECT RELATIONSHIP OF COMPLETE PATHOLOGICAL RESPONSE FOLLOWING NEO-ADJUVANT RADIO-CHEMOTHERAPY FOR RECTAL CANCER

将个体早期反应纳入新辅助放化疗后直肠癌完全病理反应的剂量-效应关系中

2025-12-050
PRE
ASO Visual Abstract: Hepatic Hypertrophy Techniques: Comparing Perioperative Outcomes of Liver Venous Deprivation (LVD) and Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy-Variants (vALPPS) among Two Referral Centers

ASO视觉摘要:肝肥大技术:比较两家转诊中心肝静脉阻断(LVD)与联合肝脏离断和门静脉结扎分阶段肝切除术变体(vALPPS)的围手术期结局

2025-11-270
PRE
Hepatic Hypertrophy Techniques: Comparing Perioperative Outcomes of Liver Venous Deprivation (LVD) and Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy-Variants (vALPPS) Among Two Referral Centers

肝肥大技术:比较两家转诊中心肝静脉阻断(LVD)和联合肝脏分隔与门静脉结扎分阶段肝切除术变体(vALPPS)的围手术期结局

2025-11-060
PRE
Alternation of mri and eus in pancreatic cancer screening could increase detection of both pancreatic and extra-pancreatic findings

MRI与EUS在胰腺癌筛查中的交替使用可能提高对胰腺及胰腺外发现的检出率。

2025-10-310
PRE
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history

MRI引导下前列腺癌病灶旁活检的应用价值:前列腺影像报告和数据系统及其活检史的影响

2025-10-130
PRE
Genomic Pathway Alterations and Their Prognostic Impact in Biliary Tract Cancer: Insights from a Multinational Cohort Treated with Cisplatin, Gemcitabine, and Durvalumab

基因组通路改变及其在胆道癌中的预后影响:来自接受顺铂、吉西他滨和度伐利尤单抗治疗的跨国队列的见解

2025-10-030
PRE
MRI in combination with Technetium-99m-sestamibi single-photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses

MRI结合Technetium-99m-sestamibi单光子发射CT/CT:一种最大化表征小肾肿块特征的新型诊断算法

2025-09-230
PRE
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT

前列腺癌患者的一日综合管理模式:PRO-FAST单次分割消融、尿道保留、高剂量率类似、机器人SBRT

2025-09-040
OAAI
Evaluation of external validity of the distal pancreatectomy fistula risk score (D-FRS) in a high-volume center

评价远端胰腺切除术瘘管风险评分(D-FRS)在外部有效性的研究:一项高容量中心的研究

2025-09-010
PRE